Compare Adaptive Biotechnologies Corp (ADPT) vs Marriott International Inc (MAR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Marriott International Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Marriott International Inc trades at $349.48 (market cap $91.14B). The key difference: Marriott International Inc is far larger — about 22.6× Adaptive Biotechnologies Corp's market cap, and Marriott International Inc pays a 0.84% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | MAR | |
|---|---|---|
Market Cap | $4.04B | $91.14B |
Sector | Health | Consumer Cyclical |
52-Week High | $25.45 | $402.54 |
52-Week Low | $12.30 | $259.04 |
Enterprise Value | $4.10B | $108.45B |
Dividend Yield | — | 0.84% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Marriott International Inc
Marriott International Inc. of Maryland is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands.
Read more on MAR →
